Chan Xie

11PUBLICATIONS
14CO-AUTHORS
Respiratory diseasesPredictive and prognostic markersBehavioural epidemiologyMolecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 07, 2026
Tenofovir Alafenamide in the Treatment of Chronic Hepatitis B Virus Infection in the High-Replicative Low-Inflammatory Phase: A 48-Week Randomized Controlled Trial.

|Apr 18, 2026
MRI-based clinical-radiologic model to predict the efficacy and prognosis of interventional with systemic therapy in advanced hepatocellular carcinoma: a multicenter study.

|Jan 29, 2026
Tenofovir Alafenamide Fumarate Reduces Virological Replication in HBeAg-Negative Patients With Normal Alanine Aminotransferase: A 48-Week Randomised Controlled Trial.

Qiumin Luo, Wenxiong Xu, Yeqiong Zhang

|Aug 11, 2025
Clinical Evaluation of M1-c6v1 Oncolytic Virus Combined with Camrelizumab and Apatinib in Advanced Hepatocellular Carcinoma.

Chan Xie, Xingrong Zheng, Songmin He

|Feb 15, 2025
Nucleolar NOL9 regulated by DNA methylation promotes hepatocellular carcinoma growth through activation of Wnt/β-catenin signaling pathway.

Xiyao Chen, Xin Song, Xingrong Zheng

|Jun 26, 2024
Serum sPD-1 and sPD-L1 as predictive biomarkers for HBsAg clearance in HBeAg-negative CHB patients undergoing IFN-based therapy.

Xiyao Chen, Boxiang Zhang, Xin Song

Pageof 2

Frequent Collaborators

5 joint publications

Liang Peng

3 joint publications

Wenxiong Xu

2 joint publications

Zhiliang Gao

2 joint publications

Xingrong Zheng